Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Current Leases (2020 - 2025)

Historic Current Leases for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to $3.6 million.

  • Relay Therapeutics' Current Leases fell 3411.11% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 3411.11%. This contributed to the annual value of $5.7 million for FY2024, which is 1537.07% up from last year.
  • Relay Therapeutics' Current Leases amounted to $3.6 million in Q3 2025, which was down 3411.11% from $3.5 million recorded in Q2 2025.
  • In the past 5 years, Relay Therapeutics' Current Leases registered a high of $5.9 million during Q1 2025, and its lowest value of $1.6 million during Q1 2021.
  • In the last 5 years, Relay Therapeutics' Current Leases had a median value of $4.4 million in 2023 and averaged $3.9 million.
  • As far as peak fluctuations go, Relay Therapeutics' Current Leases surged by 22132.35% in 2022, and later crashed by 3411.11% in 2025.
  • Over the past 5 years, Relay Therapeutics' Current Leases (Quarter) stood at $1.8 million in 2021, then surged by 131.89% to $4.3 million in 2022, then increased by 16.09% to $5.0 million in 2023, then increased by 15.37% to $5.7 million in 2024, then tumbled by 36.39% to $3.6 million in 2025.
  • Its Current Leases was $3.6 million in Q3 2025, compared to $3.5 million in Q2 2025 and $5.9 million in Q1 2025.